<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Our products &#8211; AIDIFY</title>
	<atom:link href="https://join.aidify.eu/shop/feed/" rel="self" type="application/rss+xml" />
	<link>https://join.aidify.eu</link>
	<description>Learn. Grow. AIDIFY</description>
	<lastBuildDate>Sun, 19 Apr 2026 22:06:16 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9</generator>

<image>
	<url>https://join.aidify.eu/app/uploads/2023/06/cropped-Artboard-13-1-32x32.png</url>
	<title>Our products &#8211; AIDIFY</title>
	<link>https://join.aidify.eu</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Effective collaboration between the Study Coordinator and the Clinical Research Monitor – Practical aspects of Monitoring Visits</title>
		<link>https://join.aidify.eu/product/effective-collaboration-between-the-study-coordinator-and-the-clinical-research-monitor-practical-aspects-of-monitoring-visits/</link>
					<comments>https://join.aidify.eu/product/effective-collaboration-between-the-study-coordinator-and-the-clinical-research-monitor-practical-aspects-of-monitoring-visits/#respond</comments>
		
		<dc:creator><![CDATA[Karol]]></dc:creator>
		<pubDate>Thu, 31 Jul 2025 16:02:40 +0000</pubDate>
				<guid isPermaLink="false">https://join.aidify.eu/?post_type=product&#038;p=15134</guid>

					<description><![CDATA[Master practical site monitoring visits: enhance collaboration between study coordinators and Clinical Research Monitors for efficient, compliant trials.]]></description>
										<content:encoded><![CDATA[<p>This course explores the key elements of effective collaboration between clinical trial coordinators and monitors. Focusing on the practical aspects of monitoring visits from the perspective of the clinical trial site, participants will gain insights into optimizing communication, preparing for visits, and addressing common challenges. It is intended for clinical trial site staff—particularly…</p>
<p><a href="https://join.aidify.eu/product/effective-collaboration-between-the-study-coordinator-and-the-clinical-research-monitor-practical-aspects-of-monitoring-visits/" rel="nofollow">Source</a></p>]]></content:encoded>
					
					<wfw:commentRss>https://join.aidify.eu/product/effective-collaboration-between-the-study-coordinator-and-the-clinical-research-monitor-practical-aspects-of-monitoring-visits/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Moving from hype to reality: how AI can really help tackle pharma challenges</title>
		<link>https://join.aidify.eu/product/moving-from-hype-to-reality-how-ai-can-really-help-tackle-pharma-challenges/</link>
					<comments>https://join.aidify.eu/product/moving-from-hype-to-reality-how-ai-can-really-help-tackle-pharma-challenges/#respond</comments>
		
		<dc:creator><![CDATA[Karol]]></dc:creator>
		<pubDate>Wed, 28 May 2025 19:56:41 +0000</pubDate>
				<guid isPermaLink="false">https://join.aidify.eu/?post_type=product&#038;p=14385</guid>

					<description><![CDATA[From hype to reality: learn practical AI for pharma, streamlining pharmacovigilance, medical writing, and training with real-world use cases.]]></description>
										<content:encoded><![CDATA[<p>Unique webinar (recording) co-organized by AIDIFY and Miquido, focusing on the transformative role of AI in the pharmaceutical industry. This webinar will explore how artificial intelligence is moving from hype to practical solutions, helping pharma professionals optimize processes and innovate faster. Miquido is a company employing over 200 IT enthusiasts who achieve their clients’…</p>
<p><a href="https://join.aidify.eu/product/moving-from-hype-to-reality-how-ai-can-really-help-tackle-pharma-challenges/" rel="nofollow">Source</a></p>]]></content:encoded>
					
					<wfw:commentRss>https://join.aidify.eu/product/moving-from-hype-to-reality-how-ai-can-really-help-tackle-pharma-challenges/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Key updates on GVP Module XVI Risk minimisation measures (Rev 3) and Module XVI Addendum II</title>
		<link>https://join.aidify.eu/product/key-updates-on-gvp-module-xvi-risk-minimisation-measures-rev-3-and-module-xvi-addendum-ii/</link>
					<comments>https://join.aidify.eu/product/key-updates-on-gvp-module-xvi-risk-minimisation-measures-rev-3-and-module-xvi-addendum-ii/#respond</comments>
		
		<dc:creator><![CDATA[Karol]]></dc:creator>
		<pubDate>Wed, 28 May 2025 19:56:41 +0000</pubDate>
				<guid isPermaLink="false">https://join.aidify.eu/?post_type=product&#038;p=14555</guid>

					<description><![CDATA[Stay current with GVP Module XVI Rev 3 and Addendum II: updates to risk minimisation measures (RMMs) for MAHs and EU pharmacovigilance compliance.]]></description>
										<content:encoded><![CDATA[<p>Stay up to date with the latest changes in pharmacovigilance guidance. This course provides a focused overview of key updates introduced in GVP Module XVI (Rev 3) and Addendum II, covering the latest regulatory expectations, best practices in designing and implementing risk minimisation measures, and implications for MAHs. Ideal for pharmacovigilance professionals looking to ensure compliance and…</p>
<p><a href="https://join.aidify.eu/product/key-updates-on-gvp-module-xvi-risk-minimisation-measures-rev-3-and-module-xvi-addendum-ii/" rel="nofollow">Source</a></p>]]></content:encoded>
					
					<wfw:commentRss>https://join.aidify.eu/product/key-updates-on-gvp-module-xvi-risk-minimisation-measures-rev-3-and-module-xvi-addendum-ii/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Clinical Trial First Step</title>
		<link>https://join.aidify.eu/product/clinical-trial-first-step/</link>
					<comments>https://join.aidify.eu/product/clinical-trial-first-step/#respond</comments>
		
		<dc:creator><![CDATA[Karol]]></dc:creator>
		<pubDate>Thu, 22 May 2025 04:32:32 +0000</pubDate>
				<guid isPermaLink="false">https://join.aidify.eu/?post_type=product&#038;p=14560</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[<p>JOB-SPECIFIC PROGRAMS The AIDIFY Clinical Trial First Step Program is a competency-based program crafted in line with the AIDIFY Clinical Trials Competency Framework and developed by industry experts, equips you with the necessary knowledge and skills needed to take the first steps in Clinical Trials. This program ensures you’re well-versed in functional knowledge and skills essential for…</p>
<p><a href="https://join.aidify.eu/product/clinical-trial-first-step/" rel="nofollow">Source</a></p>]]></content:encoded>
					
					<wfw:commentRss>https://join.aidify.eu/product/clinical-trial-first-step/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Token-based model</title>
		<link>https://join.aidify.eu/product/token-based-model/</link>
		
		<dc:creator><![CDATA[Bartłomiej Ochyra]]></dc:creator>
		<pubDate>Mon, 03 Feb 2025 17:42:25 +0000</pubDate>
				<guid isPermaLink="false">https://join.aidify.eu/?post_type=product&#038;p=14498</guid>

					<description><![CDATA[&#160;
<ul>
 	<li>Price: €499 + VAT / year / user -&#62; ~€6 per course</li>
 	<li>Minimum Seats: 20</li>
 	<li>Duration: 1 year</li>
 	<li>Content Limit: Unlimited</li>
 	<li>Job Search Support: Not included</li>
</ul>]]></description>
										<content:encoded><![CDATA[<p>Contact sales CORPORATE MEMBERSHIP The Token-Based Model is a flexible learning access system designed for organizations that need on-demand, scalable training solutions. Instead of committing to specific courses in advance, companies purchase tokens that can be used for any course within AIDIFY’s catalog over a 12-month period. This model provides maximum control and adaptability…</p>
<p><a href="https://join.aidify.eu/product/token-based-model/" rel="nofollow">Source</a></p>]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Entering data into the Pharmacovigilance database system</title>
		<link>https://join.aidify.eu/product/entering-data-into-the-pharmacovigilance-database-system/</link>
					<comments>https://join.aidify.eu/product/entering-data-into-the-pharmacovigilance-database-system/#respond</comments>
		
		<dc:creator><![CDATA[Karol]]></dc:creator>
		<pubDate>Mon, 22 Jul 2024 18:55:40 +0000</pubDate>
				<guid isPermaLink="false">https://join.aidify.eu/?post_type=product&#038;p=13603</guid>

					<description><![CDATA[Master pharmacovigilance data entry: learn ICSR handling, E2B (R2/R3), follow-ups, and EudraVigilance submissions in a practical PV database course.]]></description>
										<content:encoded><![CDATA[<p>Dive into the realm of pharmacovigilance with our course “Entering data into the Pharmacovigilance database system”. This tailored course is structured to impart a deep understanding of pharmacovigilance database requirements and the intricacies of handling Individual Case Safety Reports (ICSRs) using the PV database. Ideal for beginners aiming to enter or professionals seeking to deepen their…</p>
<p><a href="https://join.aidify.eu/product/entering-data-into-the-pharmacovigilance-database-system/" rel="nofollow">Source</a></p>]]></content:encoded>
					
					<wfw:commentRss>https://join.aidify.eu/product/entering-data-into-the-pharmacovigilance-database-system/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>ChatGPT in the pharmaceutical industry</title>
		<link>https://join.aidify.eu/product/chatgpt-in-the-pharmaceutical-industry/</link>
					<comments>https://join.aidify.eu/product/chatgpt-in-the-pharmaceutical-industry/#respond</comments>
		
		<dc:creator><![CDATA[Karol]]></dc:creator>
		<pubDate>Mon, 22 Jul 2024 18:55:40 +0000</pubDate>
				<guid isPermaLink="false">https://join.aidify.eu/?post_type=product&#038;p=13724</guid>

					<description><![CDATA[ChatGPT in the pharmaceutical industry: Learn AI, prompt engineering, and pharmacovigilance applications to boost productivity in pharma workflows.]]></description>
										<content:encoded><![CDATA[<p>Watch the recording from the unique educational online event co-organized by AIDIFY and Miquido, focusing on the application of Artificial Intelligence in the pharmaceutical industry. This is a unique opportunity to understand what ChatGPT is and how its capabilities can be leveraged in daily work. During interactive workshops, participants will learn how to effectively formulate prompts and…</p>
<p><a href="https://join.aidify.eu/product/chatgpt-in-the-pharmaceutical-industry/" rel="nofollow">Source</a></p>]]></content:encoded>
					
					<wfw:commentRss>https://join.aidify.eu/product/chatgpt-in-the-pharmaceutical-industry/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Navigating EU CTR 536/2014 with transitioning from CTD</title>
		<link>https://join.aidify.eu/product/navigating-eu-ctr-536-2014-with-transitioning-from-ctd/</link>
					<comments>https://join.aidify.eu/product/navigating-eu-ctr-536-2014-with-transitioning-from-ctd/#respond</comments>
		
		<dc:creator><![CDATA[Karol]]></dc:creator>
		<pubDate>Mon, 22 Jul 2024 18:55:40 +0000</pubDate>
				<guid isPermaLink="false">https://join.aidify.eu/?post_type=product&#038;p=13772</guid>

					<description><![CDATA[Navigate EU CTR 536/2014 and CTD transition with this regulatory-focused webinar; learn transitional requirements ahead of 31 January 2025.]]></description>
										<content:encoded><![CDATA[<p>The EU Clinical Trials Regulation (EU CTR) 536/2014 stands as a robust legislative framework designed to streamline and harmonize clinical trial practices throughout the European Union. Enforced since 2014, its primary objectives are to bolster patient safety, foster transparency, and uphold the highest standards of research integrity within the European clinical trials landscape.</p>
<p><a href="https://join.aidify.eu/product/navigating-eu-ctr-536-2014-with-transitioning-from-ctd/" rel="nofollow">Source</a></p>]]></content:encoded>
					
					<wfw:commentRss>https://join.aidify.eu/product/navigating-eu-ctr-536-2014-with-transitioning-from-ctd/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Introduction to safety monitoring in clinical trials</title>
		<link>https://join.aidify.eu/product/introduction-to-safety-monitoring-in-clinical-trials/</link>
					<comments>https://join.aidify.eu/product/introduction-to-safety-monitoring-in-clinical-trials/#respond</comments>
		
		<dc:creator><![CDATA[Karol]]></dc:creator>
		<pubDate>Thu, 25 Apr 2024 15:29:42 +0000</pubDate>
				<guid isPermaLink="false">https://join.aidify.eu/?post_type=product&#038;p=13396</guid>

					<description><![CDATA[Learn safety monitoring in clinical trials: SAE/SUSAR reporting, DSUR, regulatory requirements, pharmacovigilance basics, and risk management.]]></description>
										<content:encoded><![CDATA[<p>Embark on a Journey through Safety Monitoring in Clinical Trials with AIDIFY’s Comprehensive Course! Have you ever wondered about the intricate processes that ensure patient safety in clinical trials? Look no further than AIDIFY’s immersive course on safety monitoring in clinical trials! This course is your gateway to understanding the essential elements of safety monitoring that underpin…</p>
<p><a href="https://join.aidify.eu/product/introduction-to-safety-monitoring-in-clinical-trials/" rel="nofollow">Source</a></p>]]></content:encoded>
					
					<wfw:commentRss>https://join.aidify.eu/product/introduction-to-safety-monitoring-in-clinical-trials/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>SUSAR, DSUR, PLL reports</title>
		<link>https://join.aidify.eu/product/susar-dsur-pll-reports/</link>
					<comments>https://join.aidify.eu/product/susar-dsur-pll-reports/#respond</comments>
		
		<dc:creator><![CDATA[Karol]]></dc:creator>
		<pubDate>Thu, 25 Apr 2024 15:29:42 +0000</pubDate>
				<guid isPermaLink="false">https://join.aidify.eu/?post_type=product&#038;p=13398</guid>

					<description><![CDATA[Master SUSAR, DSUR and PLL reports in pharmacovigilance: learn expeditious safety reporting, risk assessment, and regulatory best practices for clinical trials.]]></description>
										<content:encoded><![CDATA[<p>Dive into AIDIFY’s enlightening course, “SUSAR, DSUR, PLL reports”! Get behind-the-scenes access and uncover the foundational knowledge of safety monitoring in clinical trials. If you’re thirsty for more in-depth details, remember we’ve got a whole array of niche courses just waiting for you. And now, let’s have guide you through this thrilling journey. Key Learning Outcomes: Course Highlights…</p>
<p><a href="https://join.aidify.eu/product/susar-dsur-pll-reports/" rel="nofollow">Source</a></p>]]></content:encoded>
					
					<wfw:commentRss>https://join.aidify.eu/product/susar-dsur-pll-reports/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
